Skip to main content
. 2020 Jul 8;103(1):295–302. doi: 10.4269/ajtmh.19-0898

Table 2.

Parameter values: medical costs and earnings loss due to filarial lymphedema and ADLA

Parameter Baseline estimate in January 2018* Sources
Annual per-person out-of-pocket medical costs for chronic filarial lymphedema US$10.09 32,33
Per-episode out-of-pocket medical costs for ADLA US$1.23 31,34,35
Average duration of ADLA (lost work days) 4 days 34,6370
Annual increase in real cost of medical care for chronic lymphedema and ADLA 3% 7176
Annual discount rate 3% 47
Average daily wage rate US$3.87 40,41,46
Annual increase in real wages 2.7% 41,7184
Average number of days worked per year 260
Percentage of work days lost annually because of chronic lymphedema 32,33,49,50,69,85
 Stages 1–2 0%
 Stage 3 20%
 Stage 4 50%
 Stages 5–6 75%
 Stage 7 100%

ADLA = acute dermatolymphangioadenitis.

*

Derivation of values is explained in the Supplement.